Markus Loeffler
Chief Tech/Sci/R&D Officer chez NH THERAGUIX SAS
Profil
Markus Loeffler is currently the Chief Medical Officer at NH TherAguix SAS since 2020.
He holds a Master's in Business Administration from INSEAD.
Postes actifs de Markus Loeffler
Sociétés | Poste | Début |
---|---|---|
NH THERAGUIX SAS | Chief Tech/Sci/R&D Officer | 01/01/2020 |
Formation de Markus Loeffler
INSEAD | Masters Business Admin |
Expériences
Fonctions occupées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
Entreprise privées | 1 |
---|---|
NH TherAguix SAS
NH TherAguix SAS Pharmaceuticals: MajorHealth Technology NH TherAguix SAS operates as a biotechnology company. The firm develops a nanodrug against cancer called AGuIX based on nanometric structuring that allows intravenous injection and the combination of the following properties to fight tumors: targeting, imaging, and treating. The company was founded by G?raldine Le Duc, Olivier Tillement and Fran?ois Lux in on December 11, 2015 and is headquartered in Meylan, France. | Health Technology |